药明康德一年投5支基金,中国药企为何集体“出海”掘金?

医药经济报
Jul 05

近期,国内医药企业海外投资动作频频。康龙化成发布公告称,其全资子公司Pharmaron UK Limited拟以自有资金3000万美元参与投资BLC Healthcare USD Fund I L.P.。该基金注册于开曼群岛,目标规模约1亿美元,将重点投资全球生命医药及生命健康领域。这一现象并非个案。据笔者不完全统计,2024年以来,包括药明康德、恒瑞医药、君实生物、信达生物等在内的多家国内领先...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10